{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:19:36Z","timestamp":1788578376724,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009068","name":"Universit\u00e4t Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.euf.2025.02.001","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:39:07Z","timestamp":1744270747000},"page":"625-637","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"11","author":[{"given":"Osama","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Mose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiwand","family":"Ahmadsei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramez","family":"Kouzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Zamboglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marvaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Jereczek-Fossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Aebersold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Shelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"49","key":"10.1016\/j.euf.2025.02.001_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta19490","article-title":"Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation","volume":"19","author":"Ramsay","year":"2015","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.euf.2025.02.001_b0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.amsu.2020.05.029","article-title":"Oncologic outcome, side effects and comorbidity of high-intensity focused ultrasound (HIFU) for localized prostate cancer. A review","volume":"56","author":"Ziglioli","year":"2020","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.euf.2025.02.001_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11934-003-0077-0","article-title":"The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection","volume":"4","author":"Chaussy","year":"2003","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.euf.2025.02.001_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.12659\/PJR.892341","article-title":"High-intensity focused ultrasound (HIFU) in localized prostate cancer treatment","volume":"80","author":"Alkhorayef","year":"2015","journal-title":"Pol J Radiol"},{"key":"10.1016\/j.euf.2025.02.001_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4103\/0970-1591.60436","article-title":"Transrectal high-intensity focused ultrasound for the treatment of prostate cancer: past, present, and future","volume":"26","author":"Mearini","year":"2010","journal-title":"Indian J Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0030","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.3171\/2017.11.FOCUS17610","article-title":"High-intensity focused ultrasound: past, present, and future in neurosurgery","volume":"44","author":"Quadri","year":"2018","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.euf.2025.02.001_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1028858","article-title":"Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: a single institution experience","volume":"12","author":"Di Lalla","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0040","doi-asserted-by":"crossref","first-page":"E179","DOI":"10.5489\/cuaj.10137","article-title":"Salvage radiotherapy after high-intensity focused ultrasound treatment for localized prostate cancer: feasibility, tolerance and efficacy","volume":"6","author":"Ripert","year":"2012","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.euf.2025.02.001_b0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2021.08.005","article-title":"An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?","volume":"81","author":"Hopstaken","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2010.42.1.1","article-title":"Salvage radiotherapy for patients with PSA relapse following radical prostatectomy: issues and challenges","volume":"42","author":"Choo","year":"2010","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.euf.2025.02.001_b0055","first-page":"1","article-title":"Best approaches and updates for prostate cancer biochemical recurrence","volume":"42","author":"Simon","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.euf.2025.02.001_b0060","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2025.02.001_b0065","unstructured":"Higgins JPT, Thomas J, Chandler J, et al, editors. Cochrane handbook for systematic reviews of interventions. London, UK: Cochrane Collaboration; 2024. https:\/\/training.cochrane.org\/handbook."},{"key":"10.1016\/j.euf.2025.02.001_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/frma.2023.1268045","article-title":"Appraising systematic reviews: a comprehensive guide to ensuring validity and reliability","volume":"8","author":"Shaheen","year":"2023","journal-title":"Front Res Metr Anal"},{"key":"10.1016\/j.euf.2025.02.001_b0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.euf.2025.02.001_b0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.euf.2025.02.001_b0085","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Ottawa, Canada: The Ottawa Hospital Research Institute; 2021. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"10.1016\/j.euf.2025.02.001_b0090","unstructured":"National Heart, Blood, and Lung Institute. Study quality assessment tools. Bethesda, MD: National Institutes of Health; 2021. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"10.1016\/j.euf.2025.02.001_b0095","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.euf.2025.02.001_b0100","unstructured":"Deeks JJ, Higgins JPT, Altman DG, McKenzie JE, Areti AV. Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, et al, editors. Cochrane handbook for systematic reviews of interventions. London, UK: Cochrane Collaboration; 2024. Chapter 10. https:\/\/training.cochrane.org\/handbook\/current\/chapter-10."},{"key":"10.1016\/j.euf.2025.02.001_b0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1471-2288-13-92","article-title":"A tutorial on sensitivity analyses in clinical trials: the what, why, when and how","volume":"13","author":"Thabane","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.euf.2025.02.001_b0110","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.3390\/jcm11154450","article-title":"Salvage radiotherapy plus androgen deprivation therapy for high-risk prostate cancer with biochemical failure after high-intensity focused ultrasound as primary treatment","volume":"11","author":"Huang","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.euf.2025.02.001_b0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.adro.2017.09.001","article-title":"Salvage image guided radiation therapy to the prostate after cryotherapy failure","volume":"3","author":"Hopper","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.acuro.2017.06.005","article-title":"Cryotherapy versus high-intensity focused ultrasound for treating prostate cancer: oncological and functional results","volume":"42","author":"Donis Canet","year":"2018","journal-title":"Actas Urol Esp"},{"key":"10.1016\/j.euf.2025.02.001_b0125","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2012.11.057","article-title":"Morbidity of focal therapy in the treatment of localized prostate cancer","volume":"63","author":"Barret","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0130","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1097\/JS9.0000000000001164","article-title":"Nonsurgical salvage options for locally recurrent prostate cancer after primary definitive radiotherapy: a systematic review and meta-analysis","volume":"110","author":"Yang","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/j.euf.2025.02.001_b0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.eururo.2020.11.010","article-title":"A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER)","volume":"80","author":"Valle","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0140","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3390\/cancers15102727","article-title":"Salvage radical prostatectomy after primary focal ablative therapy: a systematic review and meta-analysis","volume":"15","author":"Blank","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.euf.2025.02.001_b0145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1590\/s1677-5538.ibju.2021.0091","article-title":"Available evidence on HIFU for focal treatment of prostate cancer: a systematic review","volume":"48","author":"Bakavicius","year":"2022","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0150","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00345-023-04352-9","article-title":"Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected","volume":"41","author":"Duwe","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0155","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.euo.2020.12.008","article-title":"A systematic review of focal ablative therapy for clinically localised prostate cancer in comparison with standard management options: limitations of the available evidence and recommendations for clinical practice and further research","volume":"4","author":"Bates","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0160","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1200\/JCO.2016.67.0448","article-title":"Randomized phase III noninferiority study comparing two radiotherapy fractionation schedules in patients with low-risk prostate cancer","volume":"34","author":"Lee","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0165","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0170","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1200\/JCO.2016.71.7397","article-title":"Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer","volume":"35","author":"Catton","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0175","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.prro.2018.08.002","article-title":"Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO, and AUA evidence-based guideline","volume":"8","author":"Morgan","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2025.02.001_b0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1470-2045(20)30581-7","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial","volume":"22","author":"Fransson","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0190","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2403365","article-title":"Phase 3 trial of stereotactic body radiotherapy in localized prostate cancer","volume":"391","author":"van As","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2025.02.001_b0195","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11547-020-01148-4","article-title":"Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging","volume":"125","author":"Rigo","year":"2020","journal-title":"Radiol Med"},{"key":"10.1016\/j.euf.2025.02.001_b0200","article-title":"Salvage prostate stereotactic body radiation therapy after definitive cryoablation","volume":"7","author":"Lischalk","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0205","unstructured":"Jolicoeur M, Hill E. RTOG versus CTCAE score: reporting toxicity of HDR brachytherapy monotherapy for prostate cancer. Poster presented at ESTRO 38, Milan, Italy, Milan, April 26\u201330. 2019. https:\/\/www.postersessiononline.eu\/173580348_eu\/congresos\/ESTRO38\/aula\/-PV_146_ESTRO38.pdf."},{"key":"10.1016\/j.euf.2025.02.001_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104149","article-title":"Salvage radiotherapy after initial cryotherapy for localized prostate cancer: a systematic review of the literature","volume":"192","author":"Rog\u00e9","year":"2023","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.euf.2025.02.001_b0215","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.euo.2019.03.008","article-title":"Salvage local treatments after focal therapy for prostate cancer","volume":"2","author":"Marra","year":"2019","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0220","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s00345-019-02642-9","article-title":"Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review","volume":"37","author":"Marra","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0225","doi-asserted-by":"crossref","unstructured":"Storino Ramacciotti L, Abreu AL, Crouzet S, et al. Salvage treatments after focal therapy for prostate cancer - a comprehensive review. Prostate Cancer Prostat Dis. In press. https:\/\/doi.org\/10.1038\/s41391-024-00875-3.","DOI":"10.1038\/s41391-024-00875-3"},{"key":"10.1016\/j.euf.2025.02.001_b0230","first-page":"395","article-title":"11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity","volume":"13","author":"Alongi","year":"2014","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.euf.2025.02.001_b0235","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0090-4295(00)00778-0","article-title":"Salvage radiotherapy for prostate cancer recurrence after cryosurgical ablation","volume":"56","author":"Burton","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.euf.2025.02.001_b0240","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1159\/000521660","article-title":"Salvage radiotherapy for recurrent prostate cancer after high-intensity focused ultrasound therapy: quality of life and functional outcome","volume":"106","author":"Cafuta","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2025.02.001_b0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.clgc.2012.09.003","article-title":"Salvage intensity-modulated radiation therapy for locally recurrent prostate cancer after cryotherapy","volume":"11","author":"Choi","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2025.02.001_b0250","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.urology.2008.01.079","article-title":"Intensity-modulated radiotherapy of the prostate after cryotherapy: initial experience","volume":"72","author":"Hepel","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.euf.2025.02.001_b0255","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijrobp.2015.12.351","article-title":"Proton therapy as salvage treatment for local relapse of prostate cancer following cryosurgery or high-intensity focused ultrasound","volume":"95","author":"Holtzman","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2025.02.001_b0260","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.clgc.2020.03.007","article-title":"Early comparative toxicity outcomes of patients with prostate cancer receiving initial cryotherapy and radiotherapy salvage","volume":"19","author":"Jiang","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.euf.2025.02.001_b0265","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/jrr\/rrac039","article-title":"Comparing the toxicity and disease control rate of radiotherapy for prostate cancer between salvage settings after high-intensity focused ultrasound therapy and initial settings","volume":"63","author":"Kuroki","year":"2022","journal-title":"J Radiat Res"},{"key":"10.1016\/j.euf.2025.02.001_b0270","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0360-3016(01)01694-7","article-title":"Salvage external beam radiotherapy for clinical failure after cryosurgery for prostate cancer","volume":"51","author":"McDonough","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euf.2025.02.001_b0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1754-9485.13384","article-title":"Salvage radiotherapy following HiFU: an institutional series and literature review","volume":"66","author":"Mesci","year":"2022","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0280","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000345631","article-title":"Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment","volume":"90","author":"Munoz","year":"2013","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2025.02.001_b0285","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.clon.2021.10.012","article-title":"Comparative effectiveness analyses of salvage prostatectomy and salvage radiotherapy outcomes following focal or whole-gland ablative therapy (high-intensity focused ultrasound, cryotherapy or electroporation) for localised prostate cancer","volume":"34","author":"Nathan","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.euf.2025.02.001_b0290","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.urology.2008.02.064","article-title":"Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical results","volume":"72","author":"Pasticier","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.euf.2025.02.001_b0295","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2010.06.003","article-title":"Salvage radiotherapy after high-intensity focussed ultrasound for recurrent localised prostate cancer","volume":"58","author":"Riviere","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2025.02.001_b0300","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1007\/s00345-021-03700-x","article-title":"Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer","volume":"39","author":"von Hardenberg","year":"2021","journal-title":"World J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925000227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456925000227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:25:28Z","timestamp":1764321928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456925000227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2405456925000227"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2025.02.001","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salvage Radiotherapy Following Nonradiotherapy Ablative Techniques for Primary Prostate Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2025.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}